Nuclear uranium to be used in new UK cancer therapies
A groundbreaking 15-year deal will see reprocessed uranium from UK nuclear reactors used to create radiopharmaceuticals for hard-to-treat cancers. Could this be a new hope for patients?
A groundbreaking 15-year deal will see reprocessed uranium from UK nuclear reactors used to create radiopharmaceuticals for hard-to-treat cancers. Could this be a new hope for patients?
A revolutionary new drug, pridopidine, has shown significant promise in slowing the progression of Huntington's disease, offering new hope to UK families affected by the genetic condition.
Two brothers in Chicago face a devastating insurance denial for a groundbreaking gene therapy treatment, highlighting a critical gap in US healthcare coverage for rare diseases.